All In Biotech

Drug Trial Radar · NCT07323654

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study Investigating the Efficacy and Safety Profile of KT-621 Administered Orally to Adult Participants With Uncontrolled Moderate to Severe Eosinophilic Asthma

Last checked: Nov 19, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 264 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

264

Planned (sponsor's estimate)

Start

Jan 28, 2026

Primary completion

Dec 2027

Study completion Dec 2027

Sponsor

Lead sponsor
Kymera Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Jan 7, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Phase 2b study is designed to evaluate the safety and efficacy of KT-621 in participants with uncontrolled moderate to severe eosinophilic asthma. The main goals of this study are to investigate how effective KT-621 is at treating uncontrolled moderate to severe eosinophilic asthma, the safety and tolerability of KT-621, and how KT-621 behaves in the body.

Conditions

  • Eosinophilic Asthma

Interventions

  • KT-621Drug

    Oral drug

  • PlaceboOther

    Oral placebo matched to KT-621

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in pre-bronchodilator FEV1Time frame: From baseline to Week 12

Locations

81 sites in 13 countries. Site status is shown where the registry gives one.

  • Kymera Investigative Site

    Lancaster, California · Recruiting

  • Kymera Investigative Site

    Long Beach, California · Recruiting

  • Kymera Investigative Site

    Northridge, California · Recruiting

  • Kymera Investigative Site

    Redding, California · Recruiting

  • Kymera Investigative Site

    San Francisco, California · Recruiting

  • Kymera Investigative Site

    Upland, California · Recruiting

  • Kymera Investigative Site

    Aurora, Colorado · Recruiting

  • Kymera Investigative Site

    New Haven, Connecticut · Recruiting

  • Kymera Investigative Site

    Loxahatchee Groves, Florida · Recruiting

  • Kymera Investigative Site

    Miami, Florida · Recruiting

  • Kymera Investigative Site

    Miami, Florida · Recruiting

  • Kymera Investigative Site

    Miami Lakes, Florida · Recruiting

  • Kymera Investigative Site

    Orlando, Florida · Recruiting

  • Kymera Investigative Site

    Tampa, Florida · Recruiting

  • Kymera Investigative Site

    East Point, Georgia · Recruiting

  • Kymera Investigative Site

    Iowa City, Iowa · Recruiting

  • Kymera Investigative Site

    Kansas City, Kansas · Recruiting

  • Kymera Investigative Site

    Louisville, Kentucky · Recruiting

  • Kymera Investigative Site

    Boston, Massachusetts · Recruiting

  • Kymera Investigative Site

    Chapel Hill, North Carolina · Recruiting

  • Kymera Investigative Site

    Durham, North Carolina · Recruiting

  • Kymera Investigative Site

    Toledo, Ohio · Recruiting

  • Kymera Investigative Site

    Edmond, Oklahoma · Recruiting

  • Kymera Investigative Site

    Clackamas, Oregon · Recruiting

  • Kymera Investigative Site

    Philadelphia, Pennsylvania · Recruiting

  • Kymera Investigative Site

    Pittsburgh, Pennsylvania · Recruiting

  • Kymera Investigative Site

    Pittsburgh, Pennsylvania · Recruiting

  • Kymera Investigative Site

    North Charleston, South Carolina · Recruiting

  • Kymera Investigative Site

    Rock Hill, South Carolina · Recruiting

  • Kymera Investigative Site

    Chattanooga, Tennessee · Recruiting

  • Kymera Investigative Site

    Dallas, Texas · Recruiting

  • Kymera Investigative Site

    Dallas, Texas · Recruiting

  • Kymera Investigative Site

    McKinney, Texas · Recruiting

  • Kymera Investigative Site

    Madison, Wisconsin · Recruiting

  • Kymera Investigative Site

    Buenos Aires, Argentina · Recruiting

  • Kymera Investigative Site

    Concepción del Uruguay, Argentina · Recruiting

  • Kymera Investigative Site

    Lobos, Argentina · Recruiting

  • Kymera Investigative Site

    Mar del Plata, Argentina · Recruiting

  • Kymera Investigative Site

    Quilmes, Argentina · Recruiting

  • Kymera Investigative Site

    Rosario, Argentina · Recruiting

Showing 40 of 81 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.